Atellica VTLi sepsis biomarker sample comparison study

Atellica VTLi sepsis biomarker sample comparison study - Atellica VTLi sepsis biomarker study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON51331

Enrollment

150

Registered

2023-02-28

Start date

2022-11-01

Completion date

Unknown

Last updated

2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infectious diseases sepis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Patients >= 18 years old • Patients presenting at the hospital with suspected/ diagnosed infectious disease • Patients able and willing to provide written informed consent

Exclusion criteria

Exclusion criteria: • Patients younger than 18 years • Patients requiring emergency treatment • Patients with cognitive impairment or inability to understand study information • Patients previously enrolled in this study • Pregnant or breastfeeding women

Design outcomes

Primary

Measure	Time frame
To compare Atellica VTLi Sepsis values from capillary whole blood to anticoagulated whole blood and plasma from venipuncture.	—

Secondary

Measure	Time frame
To correlate the blood and plasma outcomes on the Atellica VTLi Sepsis tests to the corresponding biomarker levels measured on the routine analyzers in the laboratory. Also, to evaluate results of the sepsis tests as function of hematocrit (Hct) values.	—

Countries

Netherlands

Outcome results